Clinical prediction of failure of Lamivudine prophylaxis for hepatitis B virus-infected patients undergoing cytotoxic chemotherapy for malignancy.
about
Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention StrategiesVirologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy.Chemotherapy-related reactivation of hepatitis B infection: updates in 2013.A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic ChemotherapyHepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma.A case of hepatitis B reactivation due to the hepatitis B virus escape mutant in a patient undergoing chemotherapy.
P2860
Clinical prediction of failure of Lamivudine prophylaxis for hepatitis B virus-infected patients undergoing cytotoxic chemotherapy for malignancy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical prediction of failure ...... c chemotherapy for malignancy.
@ast
Clinical prediction of failure ...... c chemotherapy for malignancy.
@en
type
label
Clinical prediction of failure ...... c chemotherapy for malignancy.
@ast
Clinical prediction of failure ...... c chemotherapy for malignancy.
@en
prefLabel
Clinical prediction of failure ...... c chemotherapy for malignancy.
@ast
Clinical prediction of failure ...... c chemotherapy for malignancy.
@en
P2093
P2860
P356
P1476
Clinical prediction of failure ...... c chemotherapy for malignancy.
@en
P2093
Byeong Gwan Kim
Donghee Kim
Hyo Suk Lee
In Kyoung Kim
Jung-Hwan Yoon
Yoon Jun Kim
P2860
P304
P356
10.1128/AAC.00821-12
P407
P577
2012-08-13T00:00:00Z